QIAGEN and Element Biosciences, Inc. announced a strategic partnership to offer comprehensive next-generation sequencing (NGS) workflows for the Element AVITI™ System, an innovative sequencing platform.
Element’s AVITI System is a versatile benchtop sequencer offering a combination of performance, cost, and flexibility for a wide range of NGS applications. For customers...
New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment.
GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70 to 80 percent accuracy, based on a pan-cancer cohort, according to findings to be presented at...
Medidata to announce latest innovations to accelerate drug and device development to bring treatments to patients sooner
Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, will host NEXT New York 2023, the premier clinical research conference taking place in New York City...
Multi-year collaboration will enable development of complex, cutting-edge cell therapies and armoring technologies for solid tumor targets
Generate:Biomedicines and Roswell Park Comprehensive Cancer Center announced a strategic collaboration to discover and develop chimeric antigen receptor (CAR) T-cell therapies, and armoring technologies, for up to three oncology targets, including in ovarian...
TSO 500 ctDNA Version 2 delivers faster turnaround time, greater analytical sensitivity, more streamlined workflow, further enabling precision medicine.
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced a new generation of its distributed liquid biopsy assay for genomic profiling. The new TruSight™ Oncology 500 ctDNA v2...
Flagship Pioneering launched Pioneering Intelligence, an initiative of Flagship Pioneering harnessing artificial intelligence (AI) to accelerate innovation in the life sciences and beyond. Flagship marked the official launch of Pioneering Intelligence with an AI Summit that drew tech and life sciences leaders from around the globe for a day...
Rad AI Omni Reporting provides a "Speak Less, Say More" experience using GenAI pioneered by Rad AI, along with high accuracy and speed on modern architecture, as a timely response to growing dissatisfaction with current radiology reporting options
AuntMinnie.com, one of the leading voices in radiology and the medical imaging...
23andMe Holding Co. announced a new, non-exclusive data license with GSK plc which extends their collaboration and enables GSK to conduct drug target discovery and other research using the 23andMe database, the world’s largest recontactable resource of genetic and phenotypic information from consented participants. Under an amendment to their...
United Therapeutics Corporation and Miromatrix Medical Inc. announced a definitive agreement for United Therapeutics to acquire Miromatrix.
Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells. United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and...
Can-Fite signed an agreement with Collaborations Pharmaceuticals, a leading expert in Artificial Intelligence and Machine Learning
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced that it entered into an agreement with Collaborations Pharmaceuticals, Inc. (CPI) to...
